The table below shows BioNexus Gene Lab Corp's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$7.42M
$9.51M
$9.77M
$10.93M
$13.36M
$11.39M
Cost of revenue
$6.34M
$8.22M
$8.44M
$9.67M
$11.10M
$9.67M
Gross profit
$1.09M
$1.29M
$1.33M
$1.26M
$2.27M
$1.72M
R&D
$50.67K
$47.51K
$54.98K
-
-
-
SG&A
BGLC annual revenue (10-K history)
BioNexus Gene Lab Corp reported annual revenue of $7.42M for fiscal year 2025. That is down 21.9% from $9.51M in fiscal 2024. Over the 8 fiscal years shown, annual revenue grew from $212.33K (FY 2018) to $7.42M. Figures come from the company's audited annual reports as filed with the SEC.